Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Opus Genetics Inc (IRD)

77 + Investors. Track Smart Money conviction in IRD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +19
Streak
3Q ▲
Buyers last Q
65%

Smart Money Signals — IRD

Based on 77 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added IRD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
77 hedge funds hold IRD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +71% more funds vs a year ago

fund count last 6Q
+32 new funds entered over the past year (+71% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 65% buying

43 buying23 selling
Last quarter: 43 funds were net buyers (27 opened a brand new position + 16 added to an existing one). Only 23 were sellers (15 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new IRD position: 7 → 9 → 17 → 27. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 31% long-term, 43% new

■ 31% conviction (2yr+) ■ 26% medium ■ 43% new
Of the 77 current holders: 24 (31%) held >2 years, 20 held 1–2 years, and 33 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +265% but shares only +63% — price-driven

Value
+264%
Shares
+63%
Last quarter: the total dollar value of institutional holdings rose +265%, but actual share count only changed +63%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

16 → 7 → 9 → 17 → 27 new funds/Q
New funds entering each quarter: 7 → 9 → 17 → 27. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 44% veterans vs 47% newcomers

■ 44% veterans ■ 9% 1-2yr ■ 47% new
Entry-cohort mix of 79 holders: 35 (44%) are 2+ year veterans, 7 entered 1–2 years ago, and 37 (47%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 13% AUM from top-100

13% from top-100 AUM funds
18 of 77 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.1
out of 10
Moderate Exit Risk
Exit risk score 5.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IRD

In 2026 Q1, 43 hedge funds were net buyers of IRD (27 opened a new position, 16 added to an existing one), while 23 reduced or exited (15 trimmed, 8 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +19 funds (more new holders than closures). Total institutional holders: 77.

Hedge Fund Ownership: IRD

How many hedge funds hold IRD — quarterly history vs. share price
Quarterly hedge fund ownership of IRD vs. share price

Market Analysis: IRD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IRD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Opus Genetics Inc (IRD) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IRD has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
IRD
nan%
XLV
+2.1%

IRD outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
IRD
nan%
XLV
+3.2%

Since the filing became public, IRD outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 2 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
2.5
/ 10
conviction
Hedge Fund Positioning: IRD
77 + Investors

Track Smart Money conviction in IRD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 77 58 32.76%
13F Shares 46M 28M 63.45%
Total Value $204M $56M 264.72%
New Positions 27 17 +10
Increased Positions 16 18 -2
Closed Positions 8 5 +3
Reduced Positions 14 8 +6
Total Calls 2 1 100.0%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: IRD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

77 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IRD. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IRD holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BIOS Capital Management, LP 31.70% 3,683,429 $16.8M
2 Caligan Partners LP 1.84% 6,075,028 $27.6M
3 Mink Brook Asset Management LLC 1.50% 590,552 $2.7M
4 Boxer Capital Management, LLC 1.34% 2,250,000 $10.2M
5 Bleichroeder LP 0.58% 736,842 $3.4M
6 Trails Edge Capital Partners, LP 0.52% 500,000 $2.3M
7 ADAR1 Capital Management, LLC 0.50% 1,849,004 $8.4M
8 Great Point Partners LLC 0.34% 324,340 $1.5M
9 Opaleye Management Inc. 0.30% 1,120,000 $2.3M
10 Nantahala Capital Management, LLC 0.28% 1,681,330 $7.7M
11 Seven Fleet Capital Management LP 0.19% 134,242 $611K
12 Perceptive Advisors LLC 0.16% 1,835,842 $8.4M
13 Regency Capital Management Inc.\DE 0.14% 68,000 $309K
14 Stonepine Capital Management, LLC 0.13% 68,688 $313K
15 Palogic Value Management, L.P. 0.12% 65,000 $296K
16 nVerses Capital, LLC 0.12% 28,564 $130K
17 Miller Financial Services LLC 0.11% 22,000 $100K
18 Boothbay Fund Management, LLC 0.07% 1,189,113 $5.4M
19 Adage Capital Partners GP, L.L.C. 0.04% 6,029,775 $27.4M
20 Reliant Investment Partners, LLC 0.04% 10,000 $46K
21 Persistent Asset Partners Ltd 0.03% 17,919 $82K
22 First City Capital Management, Inc. 0.03% 11,836 $54K
23 Farallon Capital Management LLC 0.03% 1,000,000 $4.5M
24 Texas Capital Bank Wealth Management Services Inc 0.02% 88,500 $403K
25 Woodline Partners LP 0.02% 1,354,030 $6.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Opus Genetics Inc (IRD)

What does the Smart Money Trend signal show for IRD?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added IRD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IRD?

More buyers than sellers — 65% buying: Last quarter: 43 funds were net buyers (27 opened a brand new position + 16 added to an existing one). Only 23 were sellers (15 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IRD holders?

Smaller funds dominant — 13% AUM from top-100: 18 of 77 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held IRD?

Mixed — 31% long-term, 43% new: Of the 77 current holders: 24 (31%) held >2 years, 20 held 1–2 years, and 33 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Opus Genetics Inc (IRD) following the 2026 Q1 hedge fund 13F filings?

As of today, IRD has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), IRD has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →